Showing 1091-1100 of 1560 results for "".
- Clinical Trial Shows Durvalumab Plus Ceralasertib Boosted Immune Response in Lung Cancer Patientshttps://reachmd.com/news/clinical-trial-shows-durvalumab-plus-ceralasertib-boosted-immune-response-in-lung-cancer-patients/2457170/Credit: Unsplash/CC0 Public Domain A specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung cancer (NSCLC) overcome inherent immune resistance and reinvigorate a
- Yale-Led Research Explains Why Many Cancer Drugs Fail During Clinical Trial Testinghttps://reachmd.com/news/yale-led-research-explains-why-many-cancer-drugs-fail-during-clinical-trial-testing/2457108/Cancer drugs often don't behave as expected in clinical trials. A study published Oct. 11 in the journal Cell Chemical Biology explores why drugs under development are
- Using Cancer’s Strength to Fight Against Ithttps://reachmd.com/news/using-cancers-strength-to-fight-against-it/2457096/Scientists at the UC San Francisco (UCSF) and Northwestern Medicine may have found a way around the limitations of engineered T cells by borrowing a few tricks from cancer itself.By
- Study: This Protein May Be the ‘Glue’ That Helps COVID Virus Stickhttps://reachmd.com/news/study-this-protein-may-be-the-glue-that-helps-covid-virus-stick/2456976/When SARS-CoV-2 enters the human body, the virus’ spike protein binds to a cell, allowing the virus to infiltrate and begin replicating. A new study from Tulane University, conducted in partnership with Florida International University and published in
- Pusan National University's Breakthrough in Muscle Regeneration: Nanotech Scaffolding Supports Tissue Growthhttps://reachmd.com/news/pusan-national-universitys-breakthrough-in-muscle-regeneration-nanotech-scaffolding-supports-tissue-growth/2456967/BUSAN, South Korea, Jan. 19, 2024 /PRNewswire/ -- Tissue engineering, which involves the use of grafts or scaffolds to aid cell regeneration, is emerging as a key medical practice for treating volumetric muscle loss (VML), a condition
- Pazopanib Shows Activity in EWSR1-NFATC2 Bone Sarcomahttps://reachmd.com/news/pazopanib-shows-activity-in-ewsr1-nfatc2-bone-sarcoma/2456858/"Pazopanib is a multi-kinase inhibitor that is currently approved for treatment of advanced renal cell carcinoma and chemotherapy-refractory soft tissue sarcoma."BUFFALO, NY- January 12, 2024 – A new case report was published in
- Unravelling Individual Differences in DNA Mutation Riskshttps://reachmd.com/news/unravelling-individual-differences-in-dna-mutation-risks/2456809/Barcelona, 10 January 2024 – Mutations, which occur continuously in every cell of our bodies, are a key contributor to cancer, ageing, and neurodegeneration. While exposure to mutagenic chemicals, or mistakes in cellular processes durin
- Blood Test Distinguishes Neuroendocrine Subtype of Advanced Prostate Cancerhttps://reachmd.com/news/blood-test-distinguishes-neuroendocrine-subtype-of-advanced-prostate-cancer/2456808/Credit: Unsplash/CC0 Public Domain Like a criminal entering a witness protection program, cancer cells can shed their past and take on a new identity. Detecting such an identity switch is particularly chall
- New Trial of 'Pill-on-a-Thread' Brings Screening for Oesophageal Cancer Closerhttps://reachmd.com/news/new-trial-of-pill-on-a-thread-brings-screening-for-oesophageal-cancer-closer/2456802/The capsule sponge, known as the pill-on-a-thread, is a quick and simple test for Barrett’s oesophagus, a condition that can be a precursor to cancer. Heartburn is a common symptom of Barrett’s oesophagus, a changing of cells in the food pipe. The BEST4 trial launched at Adden
- Community Cancer Care Linked with Poorer Outcomes for Patients with a Common Head and Neck Cancerhttps://reachmd.com/news/community-cancer-care-linked-with-poorer-outcomes-for-patients-with-a-common-head-and-neck-cancer/2456734/FOR IMMEDIATE RELEASENewswise — Care for patients with human papillomavirus (HPV)-related squamous cell cancers of the oropharynx (an area in back of the throat) is shifting toward community cancer centers, but patients treated in this setting may be less likely to surviv